KATIE DAVIS: Open Payments
NPI 1447721584 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,606 in 100 payments from 18 companies in 2025. Trend: 2023 $2,593 · 2024 $2,278 · 2025 $2,606
Food & beverage: $2,473Education: $133
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 15 | $522 |
| AstraZeneca Pharmaceuticals LP | 13 | $509 |
| GlaxoSmithKline, LLC. | 24 | $453 |
| CSL Behring | 8 | $281 |
| GENZYME CORPORATION | 5 | $224 |
| Amgen Inc. | 14 | $163 |
| Ardelyx, Inc. | 6 | $150 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Cycle Pharmaceuticals Inc | 2 | $40 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $33 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, Hizentra, AIRSUPRA, TRELEGY ELLIPTA, IBSRELA, Sajazir.
Industry payments across KY — which companies pay providers there.
